Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Feb;42(1):193-200.
doi: 10.1007/s11096-019-00957-6. Epub 2019 Dec 21.

Evaluation of a method for drug-related problems identification and classification in hospital setting: applicability and reliability

Affiliations
Observational Study

Evaluation of a method for drug-related problems identification and classification in hospital setting: applicability and reliability

Ana Carolina Figueiredo Modesto et al. Int J Clin Pharm. 2020 Feb.

Abstract

Background Prescription evaluation by pharmacists has potential to improve pharmacotherapy management. It requires the use of robust methods to identify drug-related problems (DRP), which are important issues in pharmacotherapy. Objective To evaluate the applicability and reliability of Grupo de Investigação em Cuidados Farmacêuticos (GIGUF) method for prescription analysis, identification and classification of drug-related problems in inpatients prescriptions. Setting Department of Medical Clinic of a tertiary and teaching Brazilian hospital. Method An observational and retrospective study of identification and classification of drug-related problems. GIGUF method was used to evaluate prescriptions of hematological patients hospitalized between August and October 2015. The problems were categorized using GICUF-method classification. Three pharmacists performed inter-rater agreement analysis of the method using Kappa. Differences in prevalence of DRP was calculated by age, sex, pharmacotherapy complexity, length of stay and number of drugs. Main outcome measure (a) frequency and characteristics and (b) inter-rater agreement in identification and classification of the drug-related problems. Results A total of 211 problems were identified and 'inadequate dosing' was the most common problem. There was an association between the occurence of a drug-reklated problem and complexity of pharmacotherapy (p = 0.001) and number of drugs used (p = 0.010). The overall inter-rater agreement was moderate (k = 0.44 IC 95% 0.34-0.55) and the problem 'not suitable drug' (k = 0.55 IC 95% 0.44-0.66) had greater inter-rater agreement. Conclusion The method "Evaluation Drug Use Process" was useful for prescription analysis since it made the identification and classification of DRPs possible. The method demonstrated a moderate inter-rater agreement, and can contribute to pharmacotherapy management by hospital pharmacists.

Keywords: Brazil; Drug-related problems; GIGUF method; Inter-rater agreement; Pharmaceutical care.

PubMed Disclaimer

References

    1. Pharmaceutical Care Network Europe (PCNE). PCNE classification of drug-related problems (V8.01). 2017. https://www.pcne.org/upload/files/215_PCNE_classification_V8-01.pdf . Accessed on 17 Aug 2018.
    1. Maes KA, Tremp RM, Hersberger KE, Lambert ML. Demonstrating the clinical pharmacist’s activity: validation of an intervention-oriented classification system. Int J Clin Pharm. 2015;37(6):1162–71. - DOI
    1. Tigabu BM, Kaba D, Habte B. Drug-related problems among medical ward patients in Jimma university specialized hospital, Southwest Ethiopia. J Res Pharm Pract. 2014;3(1):1–5. - DOI
    1. Blix HS, Viktil KK, Reikvam A, Moger TA, Hjemaas BJ, Pretsch P, et al. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol. 2004;60(9):651–8. - DOI
    1. Malfará M, Pernassi M, Aragon D, Carlotti A. Impact of the clinical pharmacist interventions on prevention of pharmacotherapy related problems in the paediatric intensive care unit. Int J Clin Pharm. 2018;40(3):513–9. - DOI

Publication types

MeSH terms

LinkOut - more resources